ADP secretion and subsequent P2Y12 receptor signalling play a crucial role in thrombin-induced ERK2 activation in human platelets

Thrombosis and Haemostasis

Volumn 92, Issue 1, 2004, Pages 114-123

  Fälker, Knut ^a   Lange, Danica ^a   Presek, Peter ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

ADP; ERK2; P2Y12 receptor; Platelets; Thrombin

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; 2' DEOXY 6 N METHYLADENOSINE 3',5' BISPHOSPHATE; ACETYLSALICYLIC ACID; ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE DERIVATIVE; ADRENALIN; ALPHA 2A ADRENERGIC RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; PURINE P2Y12 RECEPTOR; PURINERGIC RECEPTOR BLOCKING AGENT; PURINERGIC RECEPTOR STIMULATING AGENT; THROMBIN; THROMBOXANE A2;

ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; HORMONE ACTION; HUMAN; HUMAN CELL; POSITIVE FEEDBACK; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION;

EID: 3543031018     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/th03-12-0729     Document Type: Article

References (40)

1. Gachet C. ADP receptors of platelets and their inhibition. Thromb Haemost 2001; 86: 222-32.
2. Kunapuli SP, Dorsam RT, Kim S, et al. Platelet purinergic receptors. Curr Opin Pharmacol 2003; 3: 175-80.
3. Kauffenstein G, Bergmeier W, Eckly A, et al. The P2Y12 receptor induces platelet aggregation through weak activation of the alpha(IIb) beta(3) integrin - a phosphoinositide 3-kinase-dependent mechanism. FEBS Lett 2001; 505: 281-90.
4. Jantzen HM, Milstone DS, Gousset L, et al. Impaired activation of murine platelets lacking G alpha(i2). J Clin Invest 2001; 108: 477-83.
5. Nieswandt B, Schulte V, Zywietz A, et al. Costimulation of Gi- and G12/G13-mediated signaling pathways induces integrin alpha II/beta 3 activation in platelets. J Biol Chem 2002; 277: 39493-98.
6. Hechler B, Eckly A, Ohlmann P, et al. The P2Y1 receptor, necessary but not sufficient to support full ADP-induced platelet aggregation, is not the target of the drug clopidogrel. Br J Haematol 1998; 103: 858-66.
7. Nylander S, Mattsson C, Ramstrom S, et al. The relative importance of tht ADP receptors, P2Y12 and P2Y1, in thrombin-induced platelet activation. Thromb Res 2003; 111: 65-73.
8. Kim S, Foster C, Lecchi A, et al. Protease-activated receptors 1 and 4 do not stimulate Gi signaling pathways in the absence of secreted ADP and cause human platelet aggregation independently of Gi signaling. Blood 2002; 99: 3629-36.
9. Kramer RM, Roberts EF, Strifler BA, et al. Thrombin induces activation of p38 MAP kinase in human platelets. J Biol Chem 1995; 270: 27395-8.
10. Bugaud F, Nadal-Wollbold F, Levy-Toledano S, et al. Regulation of c-Jun-NH2 terminal kinase and extracellular-signal regulated kinase in human platelets. Blood 1999; 94: 3800-5.
11. Papkoff J, Chen R, Blenis J, et al. p42 mitogen-activated protein kinase and p90 ribosomal S6 kinase are selectively phosphorylated and activated during thrombin-induced platelet activation and aggregation. Mol Cell Biol 1994; 14: 463-72.
12. Nakashima S, Chatani Y, Nakamura M, et al. Tyrosine phosphorylation and activation of mitogen-activated protein kinases by thrombin in human platelets: Possible involvement in late arachidonic acid release. Biochem Biophys Res Commun 1994; 198: 497-503.
13. Nadal F, Levy-Toledano S, Grelac F, et al. Negative regulation of mitogen-activated protein kinase activation by integrin alpha II/beta 3 in platelets. J Biol Chem 1997; 272: 22381-4.
14. McNicol A, Shibou TS, Pampolina C, et al. Incorporation of MAP kinases into the platelet cytoskeleton. Thromb Res 2001; 103: 25-34.
15. Pearson G, Robinson F, Beers Gibson T, et al. Mitogen-activated protein (MAP) kinase pathways: Regulation and physiological functions. Endocr Rev 2001; 22: 153-83.
16. Börsch-Haubold AG, Kramer RM, Watson SP. Inhibition of mitogen-activated protein kinase kinase does not impair primary activation of human platelets. Biochem J 1996; 318: 207-12.
17. McNicol A, Jackson ECG. Inhibition of the MEK/ERK pathway has no effect on agonist-induced aggregation of human platelets. Biochem Pharmacol 2003; 65: 1243-50.
18. Nadal-Wollbold F, Pawlowski M, Levy-Toledano S, et al. Platelet ERK2 activation by thrombin is dependent on calcium and conventional protein kinases C but not Raf-1 or B-Raf. FEBS Lett 2002; 531: 475-82.
19. Pawlowski M, Ragab A, Rosa JP, et al. Selective dephosphorylation of the threonine(183) residue of ERK2 upon (alpha)11b (beta)3 engagement in platelets. FEBS Lett 2002; 521: 145-51.
20. Blaukat A, Barac A, Cross MJ, et al. G Protein-coupled receptor-mediated mitogen-activated protein kinase activation through cooperation of Galpha q and Galpha i signals. Mol Cell Biol 2000; 20: 6837-48.
21. Stilz HU, Guba W, Jablonka B, et al. Discovery of an orally active non-peptide fibrinogen receptor antagonist based on the hydantoin scaffold. J Med Chem 2001; 44: 1158-76.
22. Martinson EA, Scheible S, Greinacher A, et al. Platelet phospholipase D is activated by protein kinase C via an integrin alpha IIb beta 3-independent mechanism. Biochem J 1995; 310: 623-8.
23. Baurand A, Eckly A, Bari N, et al. Desensitization of the platelet aggregation response to ADP: differential down-regulation of the P2Y1 and P2cyc receptors. Thromb Haemost 2000; 84: 484-91.
24. Born GV. Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature 1962; 194: 927-9.
25. Yang J, Wu J, Kowalska MA, et al. Loss of signaling through the G protein, Gz, results in abnormal platelet activation and altered responses to psychoactive drugs. Proc Natl Acad Sci USA 2000; 97: 9984-9.
26. Lanza F, Beretz A, Stierle A, et al. Epinephrine potentiates human platelet activation but is not an aggregating agent. Am J Physiol Heart Circ Physiol 1988; 255: H1276-88.
27. Steen VM, Holmsen H, Aarbakke G. The platelet-stimulating effect of adrenaline through alpha 2-adrenergic receptors requires simultaneous activation by a true stimulatory platelet agonist. Evidence that adrenaline per se does not induce human platelet activation in vitro. Thromb Haemost 1993; 70: 506-13.
28. Ohkubo S, Nakahata N, Ohizumi Y. Thromboxane A2 stimulates mitogen-activated protein kinase and arachidonic acid liberation in rabbit platelets. Prostaglandins 1996; 52: 403-13.
29. Oury C, Toth-Zsamboki E, Vermylen J, et al. P2X1-mediated activation of extracellular signal-regulated kinase 2 contributes to platelet secretion and aggregation induced by collagen. Blood 2002; 100: 2499-505.
30. Martinson EA, Scheible S, Marx-Grunwitz A, et al. Secreted ADP plays a central role in thrombin-induced phospholipase D activation in human platelets. Thromb Haemost 1998; 80: 976-81.
31. Baurand A, Raboisson P, Freund M, et al. Inhibition of platelet function by administration of MRS2179, a P2Y1 receptor antagonist. Eur J Pharmacol 2001; 412: 213-21.
32. Selheim F, Froyset AK, Strand I, et al. Adrenaline potentiates PI 3-kinase in platelets stimulated with thrombin and SFRLLN: role of secreted ADP. FEBS Lett 2000; 485: 62-6.
33. Offermanns S, Laugwitz K, Spicher K, et al. Proteins of the G12 family are activated via thromboxane A2 and thrombin receptors in human platelets. Proc Natl Acad Sci USA 1994; 91: 504-8.
34. Offermanns S, Toombs CF, Hu YH, et al. Defective platelet activation in G alpha(q)-deficient mice. Nature 1997; 389: 183-6.
35. Paul BZS, Jin J, Kunapuli SP. Molecular mechanism of thromboxane A2-induced platelet aggregation. J Biol Chem 1999; 274: 29108-14.
36. Rosado JA, Sage SO. The ERK cascade, a new pathway involved in the activation of store-mediated calcium entry in human platelets. Trends Cardiovas Med 2002; 12: 229-34.
37. Börsch-Haubold AG, Pasquet S, Watson SP. Direct inhibition of cyclooxygenase-1 and -2 by the kinase inhibitors SB 203580 and PD 98059. SB 203580 also inhibits thromboxane synthase. J Biol Chem 1998; 273: 28766-72.
38. 3. J Biol Chem 2001; 276: 42226-32.
39. Roger S, Pawlowski M, Habib A, et al. Costimulation of the Gi-coupled ADP receptor and the Gq-coupled TXA2 receptor is required for ERK2 activation in collagen-induced platelet aggregation. FEBS Lett 2004; 556: 227-35.
40. Soulet C, Sauzeau V, Plantavid M, et al. Gi-dependent and -independent mechanisms downstream of the P2Y12 ADP-receptor. J Thromb Haemost 2004; 2: 135-46.